News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Medtronic, Inc. (MDT) Spinal Faces Lawsuits Over Infuse Product


6/19/2013 8:00:01 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Medtronic Inc. released the results of a third-party independent review of the company’s Infuse Bone Graft product conducted by Yale University. The study, which was started in 2011, follows a year of federal investigation on Medtronic’s payment of authors who wrote studies on Infuse. The investigation turned up no wrongdoing on the company’s part, but a set of 12 recently filed lawsuits against Medtronic in May, filed on behalf of a group of patients who were treated with Infuse, has the company preparing to defend itself again. Infuse was developed and is sold from the company’s Memphis-based spinal division. Company officials couldn’t go into specific details of the lawsuits, but released a statement standing behind Infuse and preparing to “vigorously defend it in court.”

Help employers find you! Check out all the jobs and post your resume.

Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES